Form D · Other Technology

DarioHealth Corp.

New York, NY · CIK 0001533998

Offering snapshot reported Oct 7, 2025 · SEC filing

Reported sold
$17.5M
Offering amount: $17.5M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 22, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 7, 2025Initial$17,500,000No comparison10SEC filing
Jan 17, 2025Initial$6,800,000No comparison18SEC filing
Jan 17, 2025Initial$18,805,000No comparison29SEC filing
Feb 29, 2024Initial$22,422,000No comparison119SEC filing
May 16, 2023Initial$15,400,000No comparison18SEC filing
Jun 17, 2021Initial$24,000,000No comparisonNot reportedSEC filing
Feb 17, 2021Initial$31,000,000No comparison30SEC filing
Feb 3, 2021Initial$70,000,000No comparison34SEC filing
Aug 4, 2020Initial$28,590,801No comparison27SEC filing
Dec 23, 2019Amendment$21,375,000$1,346,000vs Dec 11, 2019167SEC filing
Dec 11, 2019Initial$20,029,000No comparison157SEC filing
Dec 20, 2018Initial$3,000,000No comparison5SEC filing
Mar 14, 2018Initial$6,622,565No comparison29SEC filing
Jan 23, 2017Initial$5,100,000No comparison20SEC filing
Dec 2, 2015Initial$399,999No comparison3SEC filing
Aug 7, 2015Initial$789,550No comparison22SEC filing
Jun 1, 2015Initial$461,673No comparison19SEC filing
Mar 9, 2015Initial$1,631,560No comparison20SEC filing
Oct 3, 2014Initial$4,235,000No comparison15SEC filing
Mar 5, 2014Initial$4,186,681No comparison19SEC filing
Apr 12, 2013Initial$1,675,000No comparison5SEC filing
Oct 11, 2012Initial$1,202,600No comparison19SEC filing
Sep 11, 2012Initial$500,000No comparison13SEC filing
Nov 1, 2011Initial$805,000No comparison8SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-560063

Source: Form D, filed Oct 7, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard Anderson Executive
Dror Bacher Executive
Yossi Bahagon Director
Ofer Barnea, Ph.D. Executive
Zvi Ben David Executive
Shilo Ben Zeev Director, Executive
Oded Cohen Executive
Raphael Erez Director, Executive
Yalon Farhi Director
Chen Franco Yehuda Director, Executive
Shoshana Friedman Executive
Oren Fuerst, Ph D Director
Oren Fuerst, Ph.D. Director, Executive
Mordechi Hershkowitz Executive
Malcolm Hoelein Director
Malcolm Hoenlein Director
Allen Kamer Director
Steven Kaplan Director
Jon Kaplan Director
Hila Karah Director
Peter Kash Director
Lawrence Leisure Director
Gadi Levin Executive
Dennis Matheis Director
Dennis Matthesis Director
Dennis M. Mc Grath Director
Dennis M. Mc Grath Director
Nahum D. Melumad Director
Glen D. Moller Director
Steven Nelson Executive
Jarry Olivier Executive
Erez Raphael Executive
Yoav Shaked Director
Yadin D. Shemmer Director
Adam K. Stern Director
Richard B Stone Director
Richard B. Stone Director
David Weintraub Director
David Weintraub, Md Director
Rami Yehudiha Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
322 W 57 Th St. #33 B
New York, NY, 10019